Key result
Mood disorder stratification requires novel frameworks integrating clinical staging, biomarkers, and treatment response.
Why the study?
The heterogeneity of clinical cohorts with depression and other mood disorders has limited the success and replicability of studies on causation, correlates, and treatment effectiveness.
Answers are grounded in this paper and cite their sources.
Heterogeneity may underlie replication failures in mood disorder studies; leaves open optimal stratification strategies for future research.
The recognised heterogeneity of clinical cohorts of people with depression and other mood disorders has been held to be one of the central reasons why so many studies of causation, neurobiological or psychological correlates, or the effectiveness of treatments have failed to yield significant findings or be easily replicated by independent groups.
No takes yet. Share an insight, caveat, or question.
Hickie et al. (2024) conducted an editorial in Depression and other mood disorders. Stratification of depressive and other mood disorders requires the development of new methods incorporating clinical staging, objective biomarkers, and treatment response patterns.
Synapse has enriched 10 related papers. Consider them for comparative context: